# User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

> **NCT02916576** · NA · COMPLETED · sponsor: **Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm** · enrollment: 140 (estimated)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** Blood-Glucose Monitoring Systems for self-testing

## Key facts

- **NCT ID:** NCT02916576
- **Lead sponsor:** Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2017-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02916576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02916576, "User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02916576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*